{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:55:56Z","timestamp":1793231756092,"version":"4.5.0"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Drug overdose deaths (DODs) surged with the advent of fentanyl. Recent US reports indicated a decline, but standard surveillance systems do not account for monthly variability or seasonality and require monthly population data to calculate DOD rates.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To identify when US DOD rates began to decelerate and to examine patterns by census region, drug type, and demographics.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n \n This repeated cross-sectional study of DOD rates was conducted from January 2015 to October 2024, using data from the National Center for Health Statistics and US Census Bureau. Decedents included those whose drug poisoning death was classified as unintentional, intentional (suicide or homicide), or undetermined intent, identified by\n International Statistical Classification of Diseases and Related Health Problems, 10th Revision<\/jats:italic>\n codes for external overdose causes and T codes for opioids, cocaine, and psychostimulants (eg, methamphetamine).\n <\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n \n The main outcome was change in monthly DOD rates nationally and by drug type (opioids, cocaine, or methamphetamine), census region, and demographics. Joinpoint regression evaluated significant shifts in DOD rates applying the weighted bayesian information criterion and 2-sided\n z<\/jats:italic>\n tests (\u03b1\u2009=\u2009.05).\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 800\u202f645 US residents (68.3% male; median age, 42 years [IQR, 33-54 years]) died of drug overdose between January 2015 and October 2024. The national DOD rate increased from 14.54 (95% CI, 14.52-14.55) per 100\u202f000 population in January 2015 to 33.24 (95% CI, 33.15 to 33.33) per 100\u202f000 population in August 2023. From August 2023 to February 2024, the monthly DOD rate declined by \u22120.36 (95% CI, \u22120.46 to \u22120.27) per 100\u202f000 population, accelerating to \u22120.84 (95% CI, \u22120.77 to \u22120.92) per 100\u202f000 population through October 2024 and reaching 24.29 (95% CI, 24.21-24.37) per 100\u202f000 population. Opioid-related DOD rates declined faster than stimulant-related DOD rates (\u22120.80 [95% CI, \u22120.74 to \u22120.87] vs \u22120.25 [95% CI, \u22120.23 to \u22120.27] per 100\u202f000 population). While the national DOD rate peaked in August 2023, rates peaked in the Northeast, Midwest, and South census regions in October 2022 and the West peaked a year later. By late 2023, death rates continued to accelerate among adults aged 55 years or older (0.07 per 100 000 population) and American Indian or Alaska Native (0.02 per 100 000 population), Black or African American (1.70 per 100 000 population), Hispanic or Latino (0.20 per 100 000 population), and multiracial (0.28 per 100 000 population) populations, though the pace of increase was slowing, suggesting a potential inflection point.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cross-sectional study, US DOD rates entered a new wave of sustained deceleration in 2023 after 2 decades of increase. This shift may reflect changes in drug markets, treatment access, harm reduction efforts, and population-level risk. Although the decline is encouraging, persistent disparities highlight the need for targeted interventions and improved understanding of the underlying drivers.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.14997","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T11:01:10Z","timestamp":1749726070000},"page":"e2514997","source":"Crossref","is-referenced-by-count":79,"title":["Decline in US Drug Overdose Deaths by Region, Substance, and Demographics"],"prefix":"10.1001","volume":"8","author":[{"given":"Lori Ann","family":"Post","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Northwestern Feinberg School of Medicine, Chicago, Illinois"},{"name":"Buehler Center for Health Policy and Economics, Northwestern Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ciccarone","sequence":"additional","affiliation":[{"name":"Family and Community Medicine, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Jay","family":"Unick","sequence":"additional","affiliation":[{"name":"School of Social Work, University of Maryland, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"D\u2019Onofrio","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyang","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Northwestern Feinberg School of Medicine, Chicago, Illinois"},{"name":"Buehler Center for Health Policy and Economics, Northwestern Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Lundberg","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Northwestern Feinberg School of Medicine, Chicago, Illinois"},{"name":"Buehler Center for Health Policy and Economics, Northwestern Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivangi","family":"Sharma","sequence":"additional","affiliation":[{"name":"Buehler Center for Health Policy and Economics, Northwestern Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryann","family":"Mason","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Northwestern Feinberg School of Medicine, Chicago, Illinois"},{"name":"Buehler Center for Health Policy and Economics, Northwestern Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"issue":"7","key":"zoi250489r3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.23631","article-title":"Geographic trends in opioid overdoses in the US from 1999 to 2020.","volume":"5","author":"Post","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"23","key":"zoi250489r5","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1001\/jama.2017.15971","article-title":"Underlying factors in drug overdose deaths.","volume":"318","author":"Dowell","year":"2017","journal-title":"JAMA"},{"issue":"11","key":"zoi250489r7","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1056\/NEJMe2406359","article-title":"Bending the overdose curve\u2014still not enough.","volume":"391","author":"Ciccarone","year":"2024","journal-title":"N Engl J Med"},{"issue":"48","key":"zoi250489r8","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.15585\/mmwr.mm7348a2","article-title":"Detection of illegally manufactured fentanyls and carfentanil in drug overdose deaths\u2014United States, 2021-2024.","volume":"73","author":"Tanz","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi250489r9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103236","article-title":"Pathways between COVID-19 public health responses and increasing overdose risks: a rapid review and conceptual framework.","volume":"93","author":"Nguyen","year":"2021","journal-title":"Int J Drug Policy"},{"key":"zoi250489r10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102752","article-title":"Temporal trend of drug overdose-related deaths and excess deaths during the COVID-19 pandemic: a population-based study in the United States from 2012 to 2022.","volume":"74","author":"Zhao","year":"2024","journal-title":"EClinicalMedicine"},{"key":"zoi250489r11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","article-title":"The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis.","volume":"71","author":"Ciccarone","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"4","key":"zoi250489r12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis.","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr Opin Psychiatry"},{"issue":"4","key":"zoi250489r13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jamapsychiatry.2022.0004","article-title":"Evaluation of increases in drug overdose mortality rates in the US by race and ethnicity before and during the COVID-19 pandemic.","volume":"79","author":"Friedman","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"zoi250489r14","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.2105\/AJPH.2021.306256","article-title":"COVID-19 and the drug overdose crisis: uncovering the deadliest months in the United States, January\u2013July 2020.","volume":"111","author":"Friedman","year":"2021","journal-title":"Am J Public Health"},{"issue":"2","key":"zoi250489r15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1176\/appi.ajp.2021.21060604","article-title":"Intentional drug overdose deaths in the United States.","volume":"179","author":"Han","year":"2022","journal-title":"Am J Psychiatry"},{"issue":"2","key":"zoi250489r16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.58090","article-title":"Recent drug overdose mortality decline compared with pre-COVID-19 trend.","volume":"8","author":"Kiang","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi250489r21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates.","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"issue":"3","key":"zoi250489r22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000769","article-title":"Fentanyl-driven acceleration of racial, gender and geographical disparities in drug overdose deaths in the United States.","volume":"3","author":"D\u2019Orsogna","year":"2023","journal-title":"PLOS Glob Public Health"},{"key":"zoi250489r23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","article-title":"Fentanyl in the US heroin supply: A rapidly changing risk environment.","volume":"46","author":"Ciccarone","year":"2017","journal-title":"Int J Drug Policy"},{"key":"zoi250489r24","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103402","article-title":"Fentanyl epidemic hits the US West Coast: opioid-related deaths in San Francisco from 2009-2019.","volume":"95","author":"West","year":"2021","journal-title":"Int J Drug Policy"},{"issue":"9","key":"zoi250489r25","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35603","article-title":"Trends and disparities in initiation of buprenorphine in US emergency departments, 2013-2022.","volume":"7","author":"Chhabra","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"2","key":"zoi250489r26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/jama.2024.23605","article-title":"Harm reduction strategies for people who use drugs.","volume":"333","author":"Shah","year":"2025","journal-title":"JAMA"},{"issue":"5","key":"zoi250489r27","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/add.16740","article-title":"Mortality risk among individuals who smoke opioids compared with those who inject: A propensity score-matched cohort analysis of United States national treatment data.","volume":"120","author":"Karandinos","year":"2025","journal-title":"Addiction"},{"key":"zoi250489r28","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108019","article-title":"Treatment of overdose in the synthetic opioid era.","volume":"233","author":"Skolnick","year":"2022","journal-title":"Pharmacol Ther"},{"issue":"2","key":"zoi250489r29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/ip-2023-045091","article-title":"Estimating the ratio of fatal to non-fatal overdoses involving all drugs, all opioids, synthetic opioids, heroin or stimulants, USA, 2010-2020.","volume":"30","author":"Casillas","year":"2024","journal-title":"Inj Prev"},{"issue":"3","key":"zoi250489r30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/15563650.2022.2159427","article-title":"Opioid overdoses involving xylazine in emergency department patients: a multicenter study.","volume":"61","author":"Love","year":"2023","journal-title":"Clin Toxicol (Phila)"},{"key":"zoi250489r1","unstructured":"CDC WONDER. US deaths. Centers for Disease Control and Prevention. 2024. Accessed April 30, 2025. https:\/\/wonder.cdc.gov\/"},{"key":"zoi250489r2","doi-asserted-by":"crossref","unstructured":"Hedegaard? H, Mini\u00f1o? AM, Spencer? MR, Warner? M. Drug overdose deaths in the United States, 1999\u20132020. National Center for Health Statistics data brief No. 428. December 2021. Accessed April 30, 2025. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db428.htm","DOI":"10.15620\/cdc:112340"},{"key":"zoi250489r4","doi-asserted-by":"crossref","unstructured":"Garnett? MF, Mini\u00f1o? AM. Drug overdose deaths in the United States, 2003-2023. National Center for Health Statistics data brief No. 522. December 2024. Accessed April 30, 2025. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db522.htm","DOI":"10.15620\/cdc\/170565"},{"key":"zoi250489r6","unstructured":"US overdose deaths decrease in 2023, first time since 2018. News release. National Center for Health Statistics; May 15, 2024. Accessed April 30, 2025. https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2024\/20240515.htm"},{"key":"zoi250489r17","unstructured":"National Vital Statistics System (NVSS). Centers for Disease Control and Prevention. 2024. Accessed March 12, 2025. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"zoi250489r18","unstructured":"Ahmad? FB, Cisewski? JA, Rossen? LM, Sutton? P. Provisional drug overdose death counts. National Vital Statistics System, National Center for Health Statistics, Centers for Disease Control and Prevention. 2025. Accessed May 2, 2025. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"zoi250489r19","unstructured":"Methodology for the United States population estimates: vintage 2023. US Census Bureau. December 2023. Accessed January 15, 2025. https:\/\/www2.census.gov\/programs-surveys\/popest\/technical-documentation\/methodology\/2020-2023\/methods-statement-v2023.pdf"},{"key":"zoi250489r20","unstructured":"US Census Bureau. National population totals and components of change: 2020-2024. December 2024. Accessed January 15, 2025. https:\/\/www.census.gov\/data\/tables\/time-series\/demo\/popest\/2020s-national-total.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2835230\/post_2025_oi_250489_1749071633.68132.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T11:01:14Z","timestamp":1749726074000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2835230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.14997","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]}}}